Ensign Professor of Medicine (Cardiovascular Medicine) and Professor of Cellular And Molecular Physiology; Co-Director, Yale Cardiovascular Research Center (YCVRC)
YCVRC Research Programs
Cardiovascular Development
Formation of heart and vasculature follow a complex series of steps that involve interplay of stimulatory and inhibitory signaling, guidance molecules and cross-talk among numerous cell types. A growing understanding of these events is already shedding light on many complex clinical problems and will likely result in development of new regenerative approaches to the treatment of a wide variety of cardiac illnesses. The following areas are being studied by Yale Cardiovascular Research Center investigators:
Vascular and lymphatic development
Associate Professor Tenure; Director of the Zebrafish Phenotyping Core for Precision Medicine, Internal Medicine and Genetics; Co-Director, Yale Cardiovascular Research Center (YCVRC)
Large vessel development
Professor of Medicine (Cardiovascular Medicine); Co-Director, Yale Cardiovascular Research Center (YCVRC); Professor, Genetics
Neurovascular Biology
The vascular and the nervous system are the first two systems to develop, and they share a remarkable number of features including the overall network architecture and many signaling molecules and receptors. In addition, there is a remarkable cross-talk between the two systems with peripheral nerves guiding development of peripheral arteries and arterial blood supply supporting nerve growth. This interaction extends even further with the vasculature playing an important role in modulating nervous system plasticity during development and in adult tissues.
Neural guidance of the vasculature
Ensign Professor of Medicine (Cardiovascular Medicine) and Professor of Cellular And Molecular Physiology; Co-Director, Yale Cardiovascular Research Center (YCVRC)
Neurovascular CNS niche
Signaling
Cellular responses to a variety of soluble and extracellular matrix signals are at the heart cardiovascular biology. A thorough understanding of this process can guide understanding of numerous cardiovascular pathologies from formation of arterial-venous malformations to development of cardiac hypertrophy to blood pressure regulation. The ability to manipulate these signaling events is critical to development of new classes of therapeutic agents that can promote process such as arteriogenesis or lymphangiogenesis, increase contractility of the failing heart or reverse myocardial hypertrophy.
Endothelial and smooth muscle signaling
Robert I. Levy Professor of Medicine (Cardiovascular Medicine) and Professor of Immunobiology; Associate Chief, Cardiovascular Medicine, Internal Medicine; Senior Vice Chief for Academic Development, Cardiovascular Medicine
Professor of Medicine (Cardiovascular Medicine) and Pharmacology; Co-Director, Yale Cardiovascular Research Center (YCVRC)
Myocardial signaling
Senior Research Scientist; Associate Director of Academic Research, Yale Cardiovascular Research Group
Professor of Medicine (Cardiology) and of Cellular And Molecular Physiology
Genetics
Technology advances in DNA sequencing and array analysis of gene expression have enabled comprehensive approaches to the analysis of many common and not so common cardiovascular problems. The genetics program seeks to understand genetic basis of a number of cardiovascular illnesses including early onset coronary artery disease, metabolic syndrome, sudden cardiac death and atrial fibrillation. Much of this work is carried out in close collaboration with CV geneticists at UCL.
Genetics, genomics & pharmacogenomics
Professor of Medicine (Cardiology); Co-Director Yale Cooperative Center of Excellence in Hematology, Cardiovascular Medicine
Robert W Berliner Professor of Internal Medicine (Cardiology) and Professor of Genetics; Director, Cardiovascular Genetics Program; Director, Cardiovascular Module
Stem Cells
The goal of stem cell biology investigations at the Yale Cardiovascular Research Center is to develop a thorough understanding of processes involved in cell differentiation with the view towards developments of stem cell-based regenerative therapies for cardiac and neurological diseases. At the same time, investigators are exploring the utility of iPS-derived defined cell types from patients with complex illnesses for molecular diagnostics. These investigations are being carried out in close collaborations with Department of Neurology, Yale Stem Cell Center and UCL
Stem Cell
Professor of Medicine (Cardiovascular Medicine); Section of Cardiovascular Medicine
Faculty Research Matrix
PI |
|
|
Akar | Atrial fibrillation | Remodeling, Inflammation, Pericardial Fat, telemonitoring |
Bender | Vascular biology, immunology, inflammation | Integrins, RNA stability, estrogen receptors |
Burg | Clinical research | Anger |
Chun | Vascular biology, atherosclerosis | Apelin, APJ, pulmonary artery |
Curtis | Health Services Research | Measure development; Device effectiveness |
Eichmann | Developmental biology, vascular biology, neurovascular guidance | Axon guidance receptors (Neuropilin,Robo, Netrin, Unc5b) Retina, embryo |
Giordano | Myocardial biology, metabolism, vascular biology | HIF, VHL |
Goldstein | Transplant immunology, aging biology | TLR, native immunity |
Greif | Developmental biology | Pulmonary artery |
Hirschi | Developmental biology, hemogenic endothelium, neural regeneration | hES, vascular niche, mouse, chardonnay |
Hwa | GPCR structure/function, signaling, cardiovascular pharmacogenetics | GPCR, prostaglandins, atherothrombosis, pharmacogenetics |
Jin | Developmental biology, vascular biology | BMP, hemogenic endothelium, zebrafish |
Krumholz | Health services research | Health care policy |
Lampert | Electrophysiology, stress, ICDs | Stress; ICDs |
Lansky | Interventional Clinical Research | IVUS, OCT, angiography, |
Mani | Cardiovascular genetics, atherosclerosis | LRP5 |
Martin | Vascular biology, signaling | Smooth muscle cell, mTOR, adiponectin |
McNamara | Outcomes research, CV Imaging | Coronary Artery Disease, atrial fibrillation, Interventional comparisons |
Nicoli | Developmental biology, vascular development | miRNA, zebrafish |
Qyang
|
Cardiovascular stem cell biology, cardiac development, cardiovascular tissue engineering
|
iPS, ES, Is11, Wnt
|
Sadeghi | Molecular imaging, vascular biology | Vascular remodeling, atherosclerosis, aneurysm, transplant vasculopathy, inflammation, MMPsa, av integrins, VEGF, ESDN |
Schwartz | Vascular biology, signaling | Integrins, mechanotrasnsduction |
Simons | Vascular biology, developmental biology, signaling | VEGF, FGF, synectin, syndecan-4 |
Sinusas | Molecular imaging | avß3, nanoparticles, |
Soufer | Mental Stress, Myocardial Ischemia | Neuro-Cardiology,PET, MPI |
Sugeng | Clinical imaging | 3D echocardiography |
Tirziu | Vascular biology, myocardial biology, signaling | PlGF, EC-myocyte cross-talk |
Young | myocardial biology | AMPK, stress response |
Zhuang | CV imaging & surgical/interventional procedure | Micro-CT, molecular imaging (FXIII), animal models |